By Q3 2012 Libigel extended trial and subset analysis of Bloom Trials results should be out and Bio-T-gel PDUFA Feb 14th would have passed. If these are all positive. Expect approx. $6 PPS, more if serious buyout rumors surface. Sept. to mid Dec. 2011, BPAX had a 1 year target price of $6.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.